Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2015

Open Access 01.07.2015 | Maternal-Fetal Medicine

Phosphorylated IGFBP-1 in predicting successful vaginal delivery in post-term pregnancy

verfasst von: Katarzyna Kosinska-Kaczynska, Dorota Bomba-Opon, Katarzyna Bobrowska, Szymon Kozlowski, Robert Brawura-Biskupski-Samaha, Iwona Szymusik, Piotr Wegrzyn, Miroslaw Wielgos

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Purpose

To estimate whether phosphorylated IGFBP-1 (phIGFBP-1) in cervical secretion in term and post-term pregnancies can predict spontaneous onset of labor or vaginal delivery.

Methods

A prospective cohort study of 167 women in singleton term and post-term pregnancies, was conducted at 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, between 2013 and 2014. phIGFBP-1 test (Actim Partus Medix Biochemica), ultrasound cervix assessment and Bishop score were analyzed in the study group. Spontaneous onset of labor was the primary and vaginal delivery was the secondary outcome.

Results

In 32.5 % of patients, spontaneous uterine contractions appeared. 67.5 % of women delivered vaginally, 32.5 % had cesarean section. phIGFBP-1 test predicted spontaneous onset of labor (sensitivity 0.69, specificity of 0.42) and successful vaginal delivery (0.67, 0.48). In the prediction of spontaneous delivery onset ultrasound cervical assessment and phIBFBP-1 had comparable sensitivity and in the prediction of successful vaginal birth all three tests had comparable sensitivity. The time from preinduction to spontaneous onset of delivery was significantly shorter in women with positive phIGFBP-1 test (13.65 ± 6.7 vs 20.75 ± 2.6 h; p = 0.006).

Conclusion

A test for phIGFBP1 presence might be an additional tool for predicting both spontaneous onset of labor and successful vaginal delivery in post-term pregnancies.

Introduction

Insulin-like growth factors I and II (IGF I and II) are well-known agents controlling cell and tissue growth and metabolism. Han et al. and Irwin et al. [1, 2] have shown that IGF-I and -II are synthesized in placental trophoblast and fetal membranes from 6th week of gestation. In biological fluids IGFs are bound by special proteins, designated 1–6. Insulin-like growth factor binding protein-1 (IGFBP-1) is a 25-kDa hydrophobic protein [3]. IGFBP-1 is synthetized and secreted by human adult and fetal hepatocytes, ovarian granulosa cells and decidual cells [46]. In pregnant women’s serum the concentration of IGFBP-1 increases during gestation [3]. It is also the major protein of the amniotic fluid [7]. Decidua and liver secrete predominantly phosphorylated forms of IGFBP-1, while in the amniotic fluid non-phosphorylated or less phosphorylated isoforms are present [7]. The phosphorylated form is produced mainly by human decidual cells and is present between the chorion and decidua. As the cervix matures and the labor approaches, the chorion and decidua detach and phosphorylated IGFBP-1 (phIGFBP-1) gets into the cervical secretion, thus its presence reflects decidual activation and dilatation of the internal os. Kekki et al. reported that phIGFBP-1 presence in cervical secretion is a predictor of preterm delivery [8]. This relationship was also confirmed by other authors [915]. Cervival evaluation with Bishop score and ultrasound measurement of cervical canal length are usually used to predict the spontaneous onset of labor or successful vaginal delivery. While the phIGFBP-1 presence in cervical secretion in predicting preterm labor is well established, data regarding its similar role in predicting term or post-term delivery are limited. Nuutila et al. [3] confirmed that the IGFBP-1 concentration was higher in clinically ripe than unripe cervices secretions. Basing on the same theoretical premises, the study evaluating IGFBP-1 in prediction of spontaneous and induced vaginal delivery in term and post-term pregnancies was carried out.
The aim of the study was to estimate whether insulin-like growth factor binding protein-1 (IGFBP-1) presence evaluation in cervical secretion in term and post-term pregnancies can predict spontaneous onset of labor or successful vaginal delivery in induced labors in comparison to ultrasound cervical length measurement and Bishop score.

Materials and methods

The prospective cohort study was carried out at the 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, between January 2013 and January 2014. The studied group consisted of 167 pregnant women admitted for routine induction of labor 7–10 days post-term. Patients with elective indications for cesarean section were excluded from the study. All the pregnancies were dated according to the last menstrual period and verified by the crown-rump length measured in the first trimester. None of the patients had regular uterine contractions or rupture of membranes on admission. Prior to any examination, cervical swab samples were collected with a special kit and the presence of phIGFBP-1 was evaluated by an immunoenzymometric assay (Actim Partus Medix Biochemica). The test is positive when phIGFBP-1 reaches the concentration of 10 μg/L. Cervical secretion samples were obtained by inserting a sterile swab into the cervical canal for 15 s. The swab was afterwards swirled in the extraction solution for 10 s. After the extraction the test dipstick was placed in the solution. The test was checked after 5 min: if the two lines (control line and test line) appeared, the test was considered positive. If only test line appeared, the test was negative. There were no cases of failed tests with no test line visible. Ultrasound assessment of cervical length and Bishop score evaluation of the cervix were carried out afterwards. Cervical length was measured with ultrasound transvaginal 7.5 MHz probe placed in the anterior fornix with empty bladder and the linear distance between calipers placed at the internal and external os was taken into account. All the patients had a routine ultrasound scan performed, assessing fetal biometry. All the women were qualified for labor pre-induction with Foley catheter inserted through the cervical canal and the balloon was filled with 80 ml of 0.9 % NaCl above the internal os. After 24 h the catheter was removed and subsequently labor induction was carried out if spontaneous uterine contractions had not occurred. Following the catheter removal another Bishop score evaluation of the cervix was performed. Routine labor induction was performed with intravenous infusion of oxytocin (5 units of oxytocin in 50 ml 0.9 % NaCl with increasing flow from 1.2 to 6.8 ml/h every 20 min till regular uterine contractions occurred, then the adequate flow was provided) and amniotomy when regular uterine contractions were observed. During the first stage of labor epidural analgesia was available for all the patients upon request when dilatation of the cervix reached 4 cm. Spontaneous onset of labor within 24 h was the primary outcome and successful vaginal delivery was the secondary outcome of the study. A comparison of efficacy for the three analyzed methods (physical examination of the cervix according to Bishop score, ultrasound measurement of the cervical canal and IGFBP-1 presence evaluation in the cervical secretion) in predicting the primary and the secondary outcome was performed. Neonatal birth weight and general condition according to Apgar score were also analyzed.
The study obtained the approval of the Ethics Committee of Medical University of Warsaw (number KB/209/2013) and was conducted according to the Declaration of Helsinki.
Statistical analysis was performed with Mann–Whitney U test for continuous variables and Chi-squared test for categorical variables. Cut-off points were estimated on the basis of ROC curves. Every analyzed test was characterized by sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio. A Kaplan–Meier curve was used to visualize time courses. Logistic regression analysis was performed to investigate the impact of individual factors on primary and secondary outcome. Statistica 10.0 was used for statistical analyses. p values <0.05 were considered significant and all tests were two-tailed.

Results

In five patients, phIGFBP-1 results and two ultrasound cervical measurements were missing and they were excluded from the study. Finally 160 women were available for the analysis. In 52 cases spontaneous regular uterine contractions appeared within 24 h of labor pre-induction (32.5 %). 42 of those patients delivered vaginally (80.8 %). In 108 cases labor induction was performed. After Foley catheter removal Bishop score was 9.3 on average (SD 1.4, 95 % CI 1.2–1.7), which was statistically higher than Bishop score assessed on admission (5.3, SD 2.4, 95 % CI 2.1–1.7; p < 0.01). Patients with spontaneous onset of labor had statistically lower body mass index (BMI) (average 27, SD 3.6, 95 % CI 26–28 vs average 29, SD 3.8, 95 % CI 28.3–29.8; p < 0.001) and had shorter cervix in ultrasound on admission (average 20.5 mm, SD 9, 95 % CI 18–23 vs 25.3 mm, SD 8.2, 95 % CI 23.7–26.8; p < 0.001). There were no statistically significant differences regarding age, parity, weight gain during pregnancy and days post-term between the groups of spontaneous onset of labor and labor induction.
In the nulliparous group (120 patients) spontaneous regular uterine contractions appeared in 35 % (42 women) and 55.8 % delivered vaginally (67 women). In the multiparous group the spontaneous onset of labor within 24 h appeared in 25 % of cases (10 women). All the multiparous patients delivered vaginally (40 women).
108 of all women delivered vaginally (67.5 %), 52 had cesarean section (32.5 %) and there were no cases of instrumental vaginal deliveries (vacuum extractor or forceps). Women, who delivered vaginally, were significantly older (average 31.6 years, SD 5.1, 95 % CI 4.5–5.9 vs 28.8 years, SD 3.1, 95 % CI 2.6–3.8; p < 0.001) and had lower BMI (average 27.9, SD 3.5, 95 % CI 27.2–28.6 vs 29.4, SD 4.3, 95 % CI 28.2–30.5; p = 0.003), higher initial Bishop score assessment (average 5.6, SD 2.2, 95 % CI 5.2–6 vs 4.7, SD 2.6, 95 % CI 4–5.4; p = 0.017) and shorter cervix on ultrasound examination at the time of admission (average 21.5 mm, SD 8.3, 95 % CI 19.9–23 vs 28.3 mm, SD 7.7, 95 % CI 26.2–30.4; p < 0.001). There were no cesarean sections performed among patients, who had previously delivered vaginally. There were no statistically significant differences in IGFBP-1 presence in cervical secretion between the groups of vaginal and cesarean delivery (66.67 vs 51.92 %; p = 0.07). No statistically significant differences regarding weight gain during pregnancy and days post-term were observed.
In the groups of vaginal and cesarean delivery comparable rates of patients were administered epidural analgesia during the first stage of labor (61.1 vs 50 %; p > 0.05). The most common indications for cesarean section were cervical dystocia (59.3 %) and fetal distress (37 %). There were no differences in neonatal birth weight (average 3,543 g, SD 378, 95 % CI 3,471–3,615 vs 3,549 g, SD 395, 95 % CI 3,441–3,657; p > 0.05) and general condition according to Apgar score (median 10 vs 10; p > 0.05) between the groups. 91.4 % of neonates were born in good general condition (1st min Apgar score).
The cut-off points for ultrasound cervix assessment and Bishop score were designated on the basis of ROC curves. The cut-off points to predict spontaneous onset of labor were six or more for Bishop score and 22 mm or less for ultrasound cervical length, while for predicting vaginal birth they were, respectively, 5 or more and 25 mm or less. The ROC curves are presented in Figs. 1 and 2.
phIGFBP-1 test predicted spontaneous onset of regular uterine contractions with the sensitivity of 0.69 and specificity of 0.42 (Table 1). Ultrasound measurement of cervical length had the same sensitivity (0.69) with not significantly higher specificity (0.61; p = 0.06). Bishop score had slightly lower sensitivity (0.53; p > 0.05) with the specificity of 0.55 (p > 0.05) in the prediction of spontaneous onset of labor. The time from preinduction to spontaneous onset of delivery was significantly shorter in women with positive phIGFBP-1 test (13.65 ± 6.7 vs 20.75 ± 2.6 h; p = 0.006). The Kaplan–Meier curves for the time to spontaneous delivery onset are presented in Fig. 3.
Table 1
The characteristics for phIGFBP-1, Bishop score and ultrasound cervix assessment in predicting spontaneous onset of labor and successful vaginal delivery
 
Sensitivity (95 % CI)
Specificity (95 % CI)
Positive predictive value (PPV) (95 % CI)
Negative predictive value (NPV) (95 % CI)
Positive likelihood ratio (+LR) (95 % CI)
Negative likelihood ratio (−LR) (95 % CI)
Primary outcome—spontaneous onset of labor
 IGFBP-1 presence
0.69 (0.57–0.8)
0.42 (0.36–0.47)
0.36 (0.3–0.42)
0.74 (0.64–0.83)
1.19 (0.9–1.5)
0.74 (0.43–1.18)
 Bishop score (≥6)
0.53 (0.42–0.66)
0.55 (0.49–0.61)
0.37 (0.29–0.45)
0.71 (0.64–0.78)
1.2 (0.83–1.67)
0.84 (0.57–1.18)
 Ultrasound cervix assessment (≤22 mm)
0.69 (0.57–0.8)
0.61 (0.55–0.66)
0.46 (0.38–0.53)
0.81 (0.73–0.87)
1.78 (1.28–2.35)
0.5 (0.31–0.77)
Secondary outcome—successful vaginal delivery
 IGFBP-1 presence
0.67 (0.61–0.72)
0.48 (0.36–0.6)
0.73 (0.67–0.79)
0.41 (0.31–0.51)
1.28 (0.96–1.89)
0.69 (0.46–1.07)
 Bishop score (≥5)
0.67 (0.61–0.72)
0.58 (0.46–0.69)
0.77 (0.7–0.83)
0.46 (0.36–0.54)
1.58 (1.12–2.32)
0.58 (0.41–0.86)
 Ultrasound cervix assessment (≤25 mm)
0.7 (0.65–0.75)
0.71 (0.59–0.81)
0.84 (0.77–0.89)
0.54 (0.45–0.61)
2.44 (1.59–3.98)
0.42 (0.31–0.6)
The presence of phIGFBP-1 predicted successful vaginal delivery with the sensitivity of 0.67 and the specificity of 0.48 (Table 1). Bishop score had the same sensitivity (0.67), but higher specificity (0.58; p > 0.05) and ultrasound cervix assessment had higher sensitivity (0.7; p > 0.05) and significantly higher specificity (0.71; p = 0.03) in predicting successful vaginal birth.
The further data analysis concerning patients’ parity was carried out. The studied group consisted of 120 primiparas (75 %). In the nulliparous group the sensitivity of phIGFBP-1 test in predicting spontaneous delivery onset was higher than the Bishop score (0.67 vs 0.43; p = 0.048) and not significantly lower than cervical length assessment (0.71; p > 0.05) (Table 2). Both Bishop score and ultrasound cervix measurement had higher specificity (Bishop score 0.63 vs phIGFBP-1 0.4; p = 0.006 and ultrasound cervical length 0.67 vs phIGFBP-1 0.4; p = 0.001) in the prediction of spontaneous delivery onset. In the multiparous women group the presence of phIGFBP-1 in cervical secretion predicted spontaneous onset of labor with high sensitivity (0.8, specificity 0.47). Bishop score and ultrasound cervical length measurement did not differ significantly when sensitivity and specificity were compared. phIGFBP-1 test’s sensitivity was higher than Bishop score in predicting successful vaginal labor in nulliparous women (0.71 vs 0.56), but lower than ultrasound cervical assessment (0.77), however, the differences were not significant. phIGFBP-1 test had lowest specificity (0.48 vs Bishop score: 0.58; p > 0.05; vs cervical length: 0.71; p = 0.03). As all the multiparous patients delivered vaginally, the statistical analysis of vaginal birth prediction was not carried out.
Table 2
The characteristics for phIGFBP-1, Bishop score and ultrasound cervix assessment in predicting spontaneous onset of labor and successful vaginal delivery in nulliparous and parous patients
 
Sensitivity (95 % CI)
Specificity (95 % CI)
Positive predictive value (PPV) (95 % CI)
Negative predictive value (NPV) (95 % CI)
Positive likelihood ratio (+LR) (95 % CI)
Negative likelihood ratio (−LR) (95 % CI)
Primary outcome—spontaneous onset of labor
 Nulliparous
  IGFBP-1 presence
0.67 (0.54–0.79)
0.4 (0.33–0.46)
0.37 (0.3–0.44)
0.69 (0.57–0.8)
1.11 (0.8–1.46)
0.84 (0.47–1.42)
  Bishop score (≥6)
0.43 (0.3–0.56)
0.63 (0.56–0.7)
0.38 (0.27–0.5)
0.67 (0.6–0.75)
1.15 (0.69–1.85)
0.91 (0.63–1.25)
  Ultrasound cervix assessment (≤22 mm)
0.71 (0.58–0.82)
0.67 (0.6–0.73)
0.54 (0.44–0.62)
0.81 (0.73–0.88)
2.14 (1.44–3)
0.43 (0.24–0.7)
 Parous
  IGFBP-1 presence
0.8 (0.48–0.96)
0.47 (0.36–0.52)
0.33 (0.2–0.4)
0.88 (0.68–0.98)
1.5 (0.76–2)
0.43 (0.07–1.43)
  Bishop score (≥6)
0.9 (0.63–1)
0.31 (0.21–0.34)
0.33 (0.23–0.37)
0.9 (0.6–1)
1.32 (0.8–1.5)
0.29 (0.01–1.78)
  Ultrasound cervix assessment (≤22 mm)
0.6 (0.3–0.85)
0.47 (0.37–0.55)
0.27 (0.14–0.39)
0.78 (0.61–0.92)
1.13 (0.48–0.9)
0.86 (0.27–1.9)
Secondary outcome—successful vaginal delivery
 Nulliparous
  IGFBP-1 presence
0.71 (0.62–0.78)
0.48 (0.37–0.58)
0.64 (0.57–0.71)
0.56 (0.43–0.67)
1.36 (0.99–1.88)
0.61 (0.37–1)
  Bishop score (≥5)
0.56 (0.47–0.64)
0.58 (0.47–0.68)
0.63 (0.54–0.73)
0.5 (0.4–0.59)
1.32 (0.89–2)
0.77 (0.53–1.13)
  Ultrasound cervix assessment (≤25 mm)
0.77 (0.68–0.83)
0.71 (0.6–0.8)
0.78 (0.69–0.85)
0.7 (0.59–0.79)
2.65 (1.72–4.17)
0.33 (0.21–0.53)
Multiple regression analysis regarding age, parity, BMI, neonatal birth weight, Bishop score, phIGFBP-1 presence and cervical length was performed. For the spontaneous onset of labor within 24 h significant odds ratios were shown only for BMI (OR 0.2, 95 % CI 0.06–0.6; p = 0.005) and cervical length assessment (OR 3.69, 95 % CI 1.6–8.55; p = 0.002). Odds ratios calculated for the successful vaginal birth were significant for age (OR 1.18, 95 % CI 1.07–1.3; p < 0.001) and ultrasound cervical length assessment (OR 5.16, 95 % CI 2.28–11.67; p < 0.001).

Discussion

Post-term pregnancies are associated with adverse maternal and neonatal outcome. In Danish birth-registry study, increased rates of multiple maternal and perinatal complications were found in singleton pregnancies of at least 42 weeks’ gestation [16]. The risk of fetal death in pregnancy beyond 42 weeks of gestation is twice as high as at term and increases sixfold and higher at 43 weeks [17]. Induction of labor is therefore a common procedure. It is performed in about 15–25 % of all pregnancies [18]. According to the Cochrane review, induction of labor in post-term pregnancy decreases the risk of perinatal death (RR 0.31) [19]. Although post-term gestation is defined as a pregnancy of 42 weeks or more, several large multicenter randomized studies regarding the management of pregnancy beyond 40 weeks of gestation reported favorable outcomes with routine induction as early as the beginning of 41 weeks [2022]. Although there is no sufficient data, management in low-risk post-term pregnancy is better: expectant or active, many societies of obstetricians and gynecologists recommend active management for low-risk women at 41 completed weeks. In cases of unfavorable cervix several cervical ripening methods are available, like prostaglandin preparations or labor preinduction with Foley catheter. The risk of cesarean section during labor induction is increased in post-term pregnancy and varies between 10 and 37 % [19, 2328]. In the presented study group 32.5 % of patients had cesarean section performed. The main indication for operative delivery during labor induction is cervical dystocia. According to our data almost 60 % of cesarean sections were performed due to this indication. Cesarean section during labor induction may be associated with higher risk of complications, especially excessive blood loss. A sensitive diagnostic tool to predict spontaneous onset of labor and successful vaginal delivery in labor induction in term or post-term pregnancies might be very helpful in making clinical decisions regarding the adequate management—expectant or active.
We found phIGFBP-1 test to be a predictor of spontaneous onset of labor and successful vaginal delivery in post-term pregnancies. It’s sensitivity did not differ significantly from Bishop score and ultrasound cervix assessment. As the ultrasound measurement of cervical length had significantly higher specificity in predicting both outcomes, it seems to be the best predictor of spontaneous labor onset and successful vaginal delivery. Women with the positive phIGFBP-1 test also developed regular uterine contractions earlier after labor preinduction. In the subgroup of multiparous patients all three tests had comparable sensitivity and specificity for predicting both outcomes. In the nulliparous group phIGFBP-1 presence predicted spontaneous delivery onset with significantly higher sensitivity than Bishop score, which is the most common tool for the evaluation of cervix readiness for delivery and the most common predictor of successful vaginal birth [27]. The evaluation of Bishop score is also subjective and may have a significant inter-investigator variability. The phIGFBP-1 test is the most objective method of all analyzed tools.
According to Dőgl et al. [29] IGFBP-1 has a lower sensitivity (0.45) and higher specificity (0.80) in comparison to our data. Characteristics of Bishop score were also different (sensitivity 0.24, specificity 0.92), while the ultrasound cervical length assessment was similar (sensitivity 0.67, specificity 0.58). The observed difference may be the consequence of different cut-off points for Bishop score used in our study and by Dőgl (≥5 points without a cut-off evaluation).
The adequate test for successful labor induction in post-term pregnancy is needed. We found that phIGFBP-1 presence in cervical secretion is associated with spontaneous onset of labor and successful vaginal birth. So far mostly Bishop score and cervical length assessment have been analyzed in the literature as the tools for predicting the above. Strobel et al. [30] found both of them to predict spontaneous onset of labor within 24 and 48 h in term women. Bishop score was an independent predictor in nulliparous women within 96 h. In parous patients none of them could be used to predict labor in 96 h. According to Rozenberg et al. [31] Bishop score and cervical length were closely associated with spontaneous onset of delivery within 7 days period. Both Bishop score and cervical length were strong predictors of delivery within 48 h according to Rovas et al. [32]. Also Vankayalapati et al. [33] suggested that ultrasound assessment of cervical length is a significant independent predictor of the likelihood of the onset of spontaneous delivery in nulliparous women, and of successful vaginal delivery in both nulliparous and parous women with prolonged pregnancy. According to Crane’s metaanalysis all three analyzed factors (ultrasound cervix assessment, Bishop score and fetal fibronectin) predicted successful induction of labor [34]. Cheung et al. [27] found that the only independent predictors of successful labor induction were multiparity, transvaginal cervical length and maternal height <150 cm. Also in our analysis ultrasound measurement of cervical length was a strong predictor of vaginal birth. According to our results phIGFBP-1 may also be the useful predictor of spontaneous onset of labor within 24 h and successful vaginal birth, but it’s sensitivity is comparable with other analyzed tests. In the multiparous subgroup all three tests were comparable, but in the nulliparous group phIGFBP-1 and ultrasound cervix assessment were significantly more sensitive in predicting spontaneous delivery onset and comparable in predicting vaginal birth. Therefore, the low-risk nulliparous women might be the target group for phIGFBP-1 test. Our study, analogously to Cheung et al., does not support the routine screening of phIGFBP-1 in post-term pregnancies [27].
The phIGFBP-1 bedside test is quick and easy to perform. It could be used additionally to Bishop score or ultrasound cervical length to predict successful vaginal delivery in post-term patients. As a supplementary test it could bring additional information for the adequate patients’ qualification for labor induction. It might be useful in deciding between active or expectant management. However, it is not established if the test could be recommended on economic basis. Although its cost effectiveness is yet to be determined, it seems that it could increase the costs of medical management in post-term pregnancy.

Conclusion

A test for phIGFBP1 presence might be an additional tool for predicting both spontaneous onset of labor and successful vaginal delivery in post-term pregnancies, but our study does not support the routine screening for phIGFBP-1 in prediction of vaginal birth in post-term pregnancies.

Conflict of interest

We declare that we have no conflict of interest.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Gynäkologie

Kombi-Abonnement

Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Han VK, Carter AM (2000) Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289–305CrossRefPubMed Han VK, Carter AM (2000) Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289–305CrossRefPubMed
2.
Zurück zum Zitat Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC (2001) Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase- 3 and IGF-binding protein-1 suggests paracrine interactions at the decidua: trophoblast interface during human implantation. J Clin Endocrinol Metab 86:2060–2064PubMed Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC (2001) Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase- 3 and IGF-binding protein-1 suggests paracrine interactions at the decidua: trophoblast interface during human implantation. J Clin Endocrinol Metab 86:2060–2064PubMed
3.
Zurück zum Zitat Nuutila M, Hilesmaa V, Kärkkkäinem T, Ylikorkala O, Rutanen EM (1999) Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 94:243–2249CrossRefPubMed Nuutila M, Hilesmaa V, Kärkkkäinem T, Ylikorkala O, Rutanen EM (1999) Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 94:243–2249CrossRefPubMed
4.
Zurück zum Zitat Julkunen M, Koistinen R, Aalto-Setälä K, Seppälä M, Jänne OA, Kontula K (1988) Primary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue specific expression of its mRNA. FEBS Lett 236:295–302CrossRefPubMed Julkunen M, Koistinen R, Aalto-Setälä K, Seppälä M, Jänne OA, Kontula K (1988) Primary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue specific expression of its mRNA. FEBS Lett 236:295–302CrossRefPubMed
5.
Zurück zum Zitat Kedzia A, Tarka A, Petriczko E, Pruski D, Iwaniec K (2013) Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum. Ginekol Pol 84:620–623CrossRefPubMed Kedzia A, Tarka A, Petriczko E, Pruski D, Iwaniec K (2013) Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum. Ginekol Pol 84:620–623CrossRefPubMed
6.
Zurück zum Zitat Koistinen R, Angervo M, Leinonen P, Seppälä (1993) Phosphorylation of IGFBP-1 from different sources. Growth Regul 3:34–37 Koistinen R, Angervo M, Leinonen P, Seppälä (1993) Phosphorylation of IGFBP-1 from different sources. Growth Regul 3:34–37
7.
Zurück zum Zitat Koistinen R, Angervo M, Leinonen P, Hakala T, Seppälä M (1993) Phosphorylation of IGFBP-1 increases in amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 215:189–199CrossRefPubMed Koistinen R, Angervo M, Leinonen P, Hakala T, Seppälä M (1993) Phosphorylation of IGFBP-1 increases in amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 215:189–199CrossRefPubMed
8.
Zurück zum Zitat Kekki M, Kurki T, Kärkkkäinem T, Hiilesmaa V, Paavonen J, Rutanen EM (2001) Insulin-like growth factor binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 80:546–551CrossRefPubMed Kekki M, Kurki T, Kärkkkäinem T, Hiilesmaa V, Paavonen J, Rutanen EM (2001) Insulin-like growth factor binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 80:546–551CrossRefPubMed
9.
Zurück zum Zitat Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC (1997) Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 82:1894–1898PubMed Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC (1997) Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 82:1894–1898PubMed
10.
Zurück zum Zitat Iwashita M, Sakai K, Kudo Y, Takeda Y (1998) Phosphoisoforms of insulin-like growth factor binding protein-1 in the appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 8:487–493CrossRefPubMed Iwashita M, Sakai K, Kudo Y, Takeda Y (1998) Phosphoisoforms of insulin-like growth factor binding protein-1 in the appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 8:487–493CrossRefPubMed
11.
Zurück zum Zitat Altinkaya O, Gungor T, Ozat M, Danisman N, Mollamahmutoglu L (2009) Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery. Arch Gynecol Obstet 279:279–283CrossRefPubMed Altinkaya O, Gungor T, Ozat M, Danisman N, Mollamahmutoglu L (2009) Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery. Arch Gynecol Obstet 279:279–283CrossRefPubMed
12.
Zurück zum Zitat Danti L, Prefumo F, Lojacono A, Corini S, Testori A, Frusca T (2011) The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. J Matern Fetal Neonatal Med 24:1262–1266 Danti L, Prefumo F, Lojacono A, Corini S, Testori A, Frusca T (2011) The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. J Matern Fetal Neonatal Med 24:1262–1266
13.
Zurück zum Zitat Balić D, Latifagić A, Hudić I (2008) Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions as a predictor of preterm delivery. J Matern Fetal Neonatal Med 21:297–300CrossRefPubMed Balić D, Latifagić A, Hudić I (2008) Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions as a predictor of preterm delivery. J Matern Fetal Neonatal Med 21:297–300CrossRefPubMed
14.
Zurück zum Zitat Cooper S, Lange I, Wood S, Tang S, Miller L, Ross S (2012) Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol 32:460–465CrossRefPubMed Cooper S, Lange I, Wood S, Tang S, Miller L, Ross S (2012) Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol 32:460–465CrossRefPubMed
15.
Zurück zum Zitat Riboni F, Vitulo A, Dell’avanzo M, Plebani M, Battagliarin G, Paternoster D (2011) Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet 284:1325–1329CrossRefPubMed Riboni F, Vitulo A, Dell’avanzo M, Plebani M, Battagliarin G, Paternoster D (2011) Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet 284:1325–1329CrossRefPubMed
16.
Zurück zum Zitat Olesen AW, Westergaard JG, Olesen J (2003) Perinatal and maternal complications related to postterm delivery: a national register-based study 1978–1993. Am J Obst Gynecol 189:222–227CrossRef Olesen AW, Westergaard JG, Olesen J (2003) Perinatal and maternal complications related to postterm delivery: a national register-based study 1978–1993. Am J Obst Gynecol 189:222–227CrossRef
17.
Zurück zum Zitat The American College of Obstetricians and Gynecologists Practice Bulletin (2004) Management of postterm pregnancy. clinical management guidelines for obstetrician–gynecologists, no. 55. Obstet Gynecol 104(3):639–646CrossRef The American College of Obstetricians and Gynecologists Practice Bulletin (2004) Management of postterm pregnancy. clinical management guidelines for obstetrician–gynecologists, no. 55. Obstet Gynecol 104(3):639–646CrossRef
18.
Zurück zum Zitat Riboni F, Garofalo G, Pascoli I, Vitulo A, Dell’avanzo M, Battagliarin G, Paternoster D (2012) Labour induction at term: clinical, biophysical and molecular predictive factors. Arch Gynecol Obstet 286:1123–1129CrossRefPubMed Riboni F, Garofalo G, Pascoli I, Vitulo A, Dell’avanzo M, Battagliarin G, Paternoster D (2012) Labour induction at term: clinical, biophysical and molecular predictive factors. Arch Gynecol Obstet 286:1123–1129CrossRefPubMed
20.
Zurück zum Zitat Hannah ME, Hannah WJ, Hellmann J, Hewson S, Milner R, Willan A (1992) Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med 326:1587–1592CrossRefPubMed Hannah ME, Hannah WJ, Hellmann J, Hewson S, Milner R, Willan A (1992) Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med 326:1587–1592CrossRefPubMed
21.
Zurück zum Zitat The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units (1994) A clinical trial of induction of labor versus expectant management in post-term pregnancy. Am J Obstet Gynecol 170:716–723 The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units (1994) A clinical trial of induction of labor versus expectant management in post-term pregnancy. Am J Obstet Gynecol 170:716–723
22.
Zurück zum Zitat Caughey AB, Sundaram V, Kaimal AJ, Cheng YW, Gienger A, Little SE (2009) Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess 176:1–257 Caughey AB, Sundaram V, Kaimal AJ, Cheng YW, Gienger A, Little SE (2009) Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess 176:1–257
23.
Zurück zum Zitat Seyb ST, Berka RJ, Socol ML, Dooley SL (1999) Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstet Gynecol 94:600–607CrossRefPubMed Seyb ST, Berka RJ, Socol ML, Dooley SL (1999) Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstet Gynecol 94:600–607CrossRefPubMed
24.
Zurück zum Zitat Bräne E, Olsson A, Andolf E (2014) A randomized controlled trial on early induction compared to expectant management of nulliparous women with prolonged latent phases. Acta Obstet Gynecol Scand. doi:10.1111/aogs.12447 PubMed Bräne E, Olsson A, Andolf E (2014) A randomized controlled trial on early induction compared to expectant management of nulliparous women with prolonged latent phases. Acta Obstet Gynecol Scand. doi:10.​1111/​aogs.​12447 PubMed
25.
Zurück zum Zitat Akay NÖ, Hızlı D, Yılmaz SS, Yalvaç S, Kandemir O (2012) Comparison of low-dose oxytocin and dinoprostone for labor induction in post-term pregnancies: a randomized controlled prospective study. Gynecol Obstet Invest 73:242–247CrossRefPubMed Akay NÖ, Hızlı D, Yılmaz SS, Yalvaç S, Kandemir O (2012) Comparison of low-dose oxytocin and dinoprostone for labor induction in post-term pregnancies: a randomized controlled prospective study. Gynecol Obstet Invest 73:242–247CrossRefPubMed
26.
Zurück zum Zitat Torricelli M, Novembri R, Voltolini C, Conti N, Biliotti G, Piccolini E, Cevenini G, Smith R, Petraglia F (2011) Biochemical and biophysical predictors of the response to the induction of labor in nulliparous post-term pregnancy. Am J Obstet Gynecol 204:39.e1–6 Torricelli M, Novembri R, Voltolini C, Conti N, Biliotti G, Piccolini E, Cevenini G, Smith R, Petraglia F (2011) Biochemical and biophysical predictors of the response to the induction of labor in nulliparous post-term pregnancy. Am J Obstet Gynecol 204:39.e1–6
27.
Zurück zum Zitat Cheung CW, Leung TY, Sahota DS, Chan OK, Chan LW, Fung TY, Lau TK (2010) Outcome of induction of labour using maternal characteristics, ultrasound assessment and biochemical state of the cervix. J Matern Fetal Neonatal Med 23:1406–1412CrossRefPubMed Cheung CW, Leung TY, Sahota DS, Chan OK, Chan LW, Fung TY, Lau TK (2010) Outcome of induction of labour using maternal characteristics, ultrasound assessment and biochemical state of the cervix. J Matern Fetal Neonatal Med 23:1406–1412CrossRefPubMed
28.
Zurück zum Zitat Wielgos M, Szymusik I, Kosinska-Kaczynska K, Suchonska B, Kaminski P, Banaszek-Wysoczanska A, Bomba-Opon D, Szpotanska M (2007) The influence of dinoprostone on uterine cervix ripening and the course of labor. Neuro Endocrinol Lett 28:513–517PubMed Wielgos M, Szymusik I, Kosinska-Kaczynska K, Suchonska B, Kaminski P, Banaszek-Wysoczanska A, Bomba-Opon D, Szpotanska M (2007) The influence of dinoprostone on uterine cervix ripening and the course of labor. Neuro Endocrinol Lett 28:513–517PubMed
29.
Zurück zum Zitat Dőgl M, Skogvoll E, Heimstad R (2011) Cervical insulin-like growth factor binding protein-1 (IGFBP-1) to predict spontaneous onset of labor and induction to delivery interval in post-term pregnancy. Acta Obstet Gynecol Scand 90:57–62CrossRefPubMed Dőgl M, Skogvoll E, Heimstad R (2011) Cervical insulin-like growth factor binding protein-1 (IGFBP-1) to predict spontaneous onset of labor and induction to delivery interval in post-term pregnancy. Acta Obstet Gynecol Scand 90:57–62CrossRefPubMed
30.
Zurück zum Zitat Strobel E, Sladkevicius P, Rovas L, De Smet F, Karlosson ED, Valentin L (2006) Bishop score and ultrasound assessment of the cervix for prediction of time to onset of labor and time to delivery in prolonged pregnancy. Ultrasound Obstet Gynecol 28:298–305CrossRefPubMed Strobel E, Sladkevicius P, Rovas L, De Smet F, Karlosson ED, Valentin L (2006) Bishop score and ultrasound assessment of the cervix for prediction of time to onset of labor and time to delivery in prolonged pregnancy. Ultrasound Obstet Gynecol 28:298–305CrossRefPubMed
31.
Zurück zum Zitat Rozenberg P, Goffinet F, Hessabi M (2000) Comparison of the Bishop score, ultrasonographically measured cervical length, and fetal fibronectin assay in predicting time until delivery and type of delivery at term. Am J Obstet Gynecol 182:108–113CrossRefPubMed Rozenberg P, Goffinet F, Hessabi M (2000) Comparison of the Bishop score, ultrasonographically measured cervical length, and fetal fibronectin assay in predicting time until delivery and type of delivery at term. Am J Obstet Gynecol 182:108–113CrossRefPubMed
32.
Zurück zum Zitat Rovas L, Sladkevicius P, Strobel E, De Smet F, De Moor B, Valentin L (2006) Three-dimensional ultrasound assessment of the cervix for predicting time to spontaneous onset of labor and time to delivery in prolonged pregnancy. Ultrasound Obstet Gynecol 28:306–311CrossRefPubMed Rovas L, Sladkevicius P, Strobel E, De Smet F, De Moor B, Valentin L (2006) Three-dimensional ultrasound assessment of the cervix for predicting time to spontaneous onset of labor and time to delivery in prolonged pregnancy. Ultrasound Obstet Gynecol 28:306–311CrossRefPubMed
33.
Zurück zum Zitat Vankayalapati P, Sethna F, Roberts N, Ngeh N, Thilaganathan B, Bhide A (2008) Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery. Ultrasound Obstet Gynecol 31:328–331CrossRefPubMed Vankayalapati P, Sethna F, Roberts N, Ngeh N, Thilaganathan B, Bhide A (2008) Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery. Ultrasound Obstet Gynecol 31:328–331CrossRefPubMed
34.
Zurück zum Zitat Crane JM (2006) Factors predicting labor induction success: a critical analysis. Clin Obstet Gynecol 49:573–584CrossRefPubMed Crane JM (2006) Factors predicting labor induction success: a critical analysis. Clin Obstet Gynecol 49:573–584CrossRefPubMed
Metadaten
Titel
Phosphorylated IGFBP-1 in predicting successful vaginal delivery in post-term pregnancy
verfasst von
Katarzyna Kosinska-Kaczynska
Dorota Bomba-Opon
Katarzyna Bobrowska
Szymon Kozlowski
Robert Brawura-Biskupski-Samaha
Iwona Szymusik
Piotr Wegrzyn
Miroslaw Wielgos
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3577-x

Weitere Artikel der Ausgabe 1/2015

Archives of Gynecology and Obstetrics 1/2015 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.